BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35916828)

  • 1. Retrospective review of re-positive qPCR tests for SARS-CoV: do they indicate presence of reinfection?
    Temiz H; Özbek E; Yıldız Zeyrek F
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5278-5284. PubMed ID: 35916828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients.
    Slezak J; Bruxvoort K; Fischer H; Broder B; Ackerson B; Tartof S
    Clin Microbiol Infect; 2021 Dec; 27(12):1860.e7-1860.e10. PubMed ID: 34419576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection.
    Murillo-Zamora E; Mendoza-Cano O; Delgado-Enciso I; Hernandez-Suarez CM
    Public Health; 2021 Apr; 193():113-115. PubMed ID: 33774512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study.
    Turbett SE; Tomkins-Tinch CH; Anahtar MN; Dugdale CM; Hyle EP; Shenoy ES; Shaw B; Egbuonu K; Bowman KA; Zachary KC; Adams GC; Hooper DC; Ryan ET; LaRocque RC; Bassett IV; Triant VA; Siddle KJ; Rosenberg E; Sabeti PC; Schaffner SF; MacInnis BL; Lemieux JE; Charles RC
    Clin Infect Dis; 2023 Mar; 76(5):850-860. PubMed ID: 36268576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples].
    Erman Daloğlu A; Er H; Sepin Özen N; Çekin Y
    Mikrobiyol Bul; 2022 Apr; 56(2):263-273. PubMed ID: 35477229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England.
    Lacy J; Mensah A; Simmons R; Andrews N; Siddiqui MR; Bukasa A; O'Boyle S; Campbell H; Brown K
    Epidemiol Infect; 2022 May; 150():e109. PubMed ID: 35607808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ecological study on reinfection rates using a large dataset of RT-qPCR tests for SARS-CoV-2 in Santiago of Chile.
    Acuña-Castillo C; Barrera-Avalos C; Bachelet VC; Milla LA; Inostroza-Molina A; Vidal M; Luraschi R; Vallejos-Vidal E; Mella-Torres A; Valdés D; Reyes-López FE; Imarai M; Rojas P; Sandino AM
    Front Public Health; 2023; 11():1191377. PubMed ID: 37492136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of SARS-CoV-2 RNA in Upper Respiratory Swap Samples by Pooling Method.
    Tok YT; Kuşkucu MA; Erdem H; Sarıbal D; Salman Yılmaz S; Nohut OK; Karaali R; Balkan İİ; Mete B; Tabak ÖF; Aygün G; Midilli K
    Balkan Med J; 2022 Jan; 39(1):48-54. PubMed ID: 34928231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2.
    Sharma R; Sardar S; Mohammad Arshad A; Ata F; Zara S; Munir W
    Am J Case Rep; 2020 Dec; 21():e927154. PubMed ID: 33257644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Strategy for the Detection of SARS-CoV-2 Variants Based on Multiplex PCR-Mass Spectrometry Minisequencing Technology.
    Zhao F; Lu J; Lu B; Qin T; Wang X; Hou X; Meng F; Xu X; Li T; Zhou H; Zhang J; Kan B; Huang Y; Zhang Z; Xiao D
    Microbiol Spectr; 2021 Dec; 9(3):e0126721. PubMed ID: 34787499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic evidence for reinfection with SARS-CoV-2: a case study.
    Tillett RL; Sevinsky JR; Hartley PD; Kerwin H; Crawford N; Gorzalski A; Laverdure C; Verma SC; Rossetto CC; Jackson D; Farrell MJ; Van Hooser S; Pandori M
    Lancet Infect Dis; 2021 Jan; 21(1):52-58. PubMed ID: 33058797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective cross-sectional observational study of SARS-CoV-2 reinfection in La Ribera Health Department, Valencia, Spain.
    Belloch García SL
    J Med Microbiol; 2022 Oct; 71(10):. PubMed ID: 36301607
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-CoV-2 reinfection and COVID-19 severity.
    Nguyen NN; Houhamdi L; Hoang VT; Delerce J; Delorme L; Colson P; Brouqui P; Fournier PE; Raoult D; Gautret P
    Emerg Microbes Infect; 2022 Dec; 11(1):894-901. PubMed ID: 35264078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of SARS-CoV-2 Detection by Rapid Antigen and by Three Commercial RT-qPCR Tests: A Study from Martin University Hospital in Slovakia.
    Dankova Z; Novakova E; Skerenova M; Holubekova V; Lucansky V; Dvorska D; Brany D; Kolkova Z; Strnadel J; Mersakova S; Janikova K; Samec M; Pokusa M; Petras M; Sarlinova M; Kasubova I; Loderer D; Sadlonova V; Kompanikova J; Kotlebova N; Kompanikova A; Hrnciarova M; Stanclova A; Antosova M; Dzian A; Nosal V; Kocan I; Murgas D; Krkoska D; Calkovska A; Halasova E
    Int J Environ Res Public Health; 2021 Jul; 18(13):. PubMed ID: 34280974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 48-Year-Old Immunocompetent Female Resident of Southern Florida with Confirmed Reinfection with P.1 (Gamma) Variant of SARS-CoV-2.
    Kim M; Poon KK; Miller N; Rubio-Gomez H
    Am J Case Rep; 2022 Jan; 23():e935329. PubMed ID: 35041639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reinfections from SARS-CoV-2: A Retrospective Study from the Gyncentrum Genetic Laboratory in Sosnowiec, Poland, April 2020 to July 2022.
    Morawiec E; Bednarska-Czerwińska A; Pudełko A; Zmarzły N; Rojczyk E; Madej K; Sobański D; Staszkiewicz R; Ossowski P; Boroń-Kaczmarska A; Zapletal-Pudełko K; Boroń D; Grabarek BO
    Med Sci Monit; 2023 Mar; 29():e939452. PubMed ID: 36964642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.